Production (Stage)
Amneal Pharmaceuticals, Inc.
AMRX
$7.16
-$0.03-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 139.24% | -19,823.72% | -102.60% | 106.54% | 7.10% |
| Total Depreciation and Amortization | -9.03% | 12.16% | 6.10% | 0.08% | -2.47% |
| Total Amortization of Deferred Charges | -74.23% | 1,734.49% | 54.45% | -86.29% | 45.86% |
| Total Other Non-Cash Items | -0.33% | -10.37% | 14.42% | -8.14% | -69.06% |
| Change in Net Operating Assets | -586.75% | -48.90% | 175.41% | -373.67% | -122.30% |
| Cash from Operations | -93.73% | -16.71% | 257.50% | 999.25% | -103.25% |
| Capital Expenditure | 37.13% | -31.28% | -59.87% | -6.40% | 14.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -100.00% | -- | -- |
| Other Investing Activities | -600.00% | 83.33% | -380.00% | 92.27% | 51.26% |
| Cash from Investing | -10.83% | 22.47% | -220.37% | 67.28% | 37.65% |
| Total Debt Issued | -- | -- | -- | -100.00% | -85.31% |
| Total Debt Repaid | -324.11% | 36.32% | -223.05% | 57.40% | 75.86% |
| Issuance of Common Stock | -54.30% | -75.53% | 72.35% | 1,178.57% | -34.88% |
| Repurchase of Common Stock | -5,491.47% | -99.48% | -22.01% | 97.80% | -4,523.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.75% | 2.27% | 32.94% | -1,295.45% | 99.64% |
| Cash from Financing | 36.01% | 33.72% | -163.20% | -51.53% | 77.04% |
| Foreign Exchange rate Adjustments | 36.49% | -10,671.43% | 106.93% | 38.79% | -182.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -224.83% | 39.52% | 1,539.75% | 95.80% | -1,456.86% |